Back to the US 🌎 ! As announced, we are attending the 4th Annual iPSC Drug Development & Manufacturing Summit to present our latest lab-results regarding these cell-types. We want to accelerate process scale-up with those sensitive cells. Come around at Booth #6 to discuss with Patrick Bongartz and Paul Alexander Fliser about your opportunities to leverage your process to the next stage. 📈
BioThrust’s Post
More Relevant Posts
-
Are you facing challenges in small molecule drug development? Check out our latest infographic, "Tackling The Toughest Small Molecule Challenges," to discover strategies for accelerating your #API programs. Gain insights on partnering with a strategic #CDMO that brings the expertise and flexibility needed to navigate the complexities of small molecule drug development and manufacturing. #DrugDevelopment #SmallMolecules
To view or add a comment, sign in
-
🧪 Have You Performed a Proof of Concept Lyophilization Study? ❄️ At Biopharma Technology LLC and Biopharma Group, we understand that proof of concept studies are crucial for overcoming product or process development challenges, whether at the R&D or manufacturing scale. Get in touch to find out more about our CDMO capabilities! #BTLLC #CDMO #Lyophilization
To view or add a comment, sign in
-
The landscape of injectable drug development is always evolving, with new trends and challenges emerging constantly – and our leadership team stays at the forefront of all these new developments! Dr. Claus Feussner, SVP of Development Service, recently sat down for a roundtable hosted by DCAT (Drug, Chemical & Associated Technologies Association) to share some of his insights for the Value Chain Insights series. As a member of the DCAT Editorial Committee, this was a valuable opportunity to discuss some of the key trends and issues shaping the #pharma industry, including: • The rise of complex drug formulations 📈 • Evolving regulatory requirements 🌐 • Advances in #asepticfilling technologies ⏏️ Read the full write-up in the article linked below and share your thoughts in the comments! https://lnkd.in/ec-A4MNg
To view or add a comment, sign in
-
Manufacturing USA convenes industry, academia, non-profits, and government to drive innovation. Take a look at these fantastic examples in a new article from Manufacturing USA https://lnkd.in/gMKGSBMh
What happens when you bring together partners from industry, academia, and the government to collaborate in a neutral, pre-competitive environment? The answer: manufacturing innovation. Thanks to the efforts of the 17 Manufacturing USA institutes, including RAPID Manufacturing Institute®, CESMII, NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals, and NextFlex, companies can join one or more institutes to help accelerate research and development (R&D) for advanced manufacturing applications and gain exposure to new industry partners. Learn more in our latest article: https://lnkd.in/eqR2CwGp #AdvancedManufacturing #IntellecturalProperty #MFGUSA
To view or add a comment, sign in
-
Fast technology change follows a fascinating pattern: Industry works with academia and government on proof-of-concept projects. Developers own their IP but still have to share the outcomes. Before they can compete, they must cooperate. Here's how it works in manufacturing.
What happens when you bring together partners from industry, academia, and the government to collaborate in a neutral, pre-competitive environment? The answer: manufacturing innovation. Thanks to the efforts of the 17 Manufacturing USA institutes, including RAPID Manufacturing Institute®, CESMII, NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals, and NextFlex, companies can join one or more institutes to help accelerate research and development (R&D) for advanced manufacturing applications and gain exposure to new industry partners. Learn more in our latest article: https://lnkd.in/eqR2CwGp #AdvancedManufacturing #IntellecturalProperty #MFGUSA
To view or add a comment, sign in
-
Prof. Gerard Capellades of Rowan University will be presenting “Crystallization as a Purification Process: Visualizing Impurity Retention and its Effects on Crystal Properties”, at the 5th Pharma Crystallization Summit in Session 2 - Particle Engineering to Address Formulation Challenge. You can read the abstract at Crystallization as a Purification Process: https://lnkd.in/eyXhK56b Please register now to secure your seat, at crystallizationsummit.com We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool
To view or add a comment, sign in
-
𝙁𝘿𝘼 𝙐𝙣𝙫𝙚𝙞𝙡𝙨 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙮 𝙩𝙤 𝘼𝙘𝙘𝙚𝙡𝙚𝙧𝙖𝙩𝙚 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣 𝙞𝙣 𝘿𝙧𝙪𝙜 𝙈𝙖𝙣𝙪𝙛𝙖𝙘𝙩𝙪𝙧𝙞𝙣𝙜 𝙖𝙣𝙙 𝘽𝙞𝙤𝙩𝙚𝙘𝙝 💊🌍 The FDA has outlined its plans to support new drug manufacturing technologies as part of its commitments under the latest user fee program. This includes optimizing programs like CDER’s Emerging Technology Program and CBER’s Advanced Technologies Team to streamline advanced discussions before submissions. As drug manufacturing grows more complex and tech-driven, international harmonization remains a key regulatory challenge. With CBER Director Peter Marks emphasizing the need for quick action on biologics for rare diseases and emerging threats, the next five years will be pivotal for innovation. https://lnkd.in/e4-JWPD5 #DrugManufacturing #Biotech #FDA
FDA drafts new strategy to boost the use of advanced manufacturing tech
endpts.com
To view or add a comment, sign in
-
CiVentiChem major expansion coincides with the company’s 30th anniversary! Read the full press release in Pharma's Almanac below That's Nice #RSMs #MedChem #ProcessChemistry #ProcessOptimization #ComplexChemistry #SimplifyYourOutsourcing Pharma Expanse
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
pharmasalmanac.com
To view or add a comment, sign in
-
🏎️ Quick video explaining the difference between #perfusion bio manufacturing and full #continuousmanufacturing. 🙈Looking forward to the comments.
Executive Vice President | Head of Partnering and Transformation Just - Evotec Biologics & Cyprotex | B2B Biotech | VC | Early and Commercial stage | MD | MBA | Scientist by heart
For the start of the week, Nick Hutchinson and I created a brief video addressing a common query from our customers: the distinction between perfusion and 'true' continuous manufacturing, like it being run at Just - Evotec Biologics If you want to learn more - contact me, Nick, or our Team Jon Gunther, PhD, MBA, Eric Eith, Martha Z., Todd Ireland, Nigel Shipston, Christophe Martin, Amanda Jahn
To view or add a comment, sign in
1,928 followers